StockData
Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd. (CANF) stock

CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 1/30
$1.53−0.03 (-1.92%)

Close on Nov 17, 2026Market cap $2.00MP/E –Yield –

Can-Fite BioPharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Can-Fite BioPharma's pe ratio was 3.1× on Feb 28, 2018, against 3.6× a year earlier. Over the last 2 years it ranged from 2.4× to 5.3×, with a median of 3.6×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2018Feb 28, 20183.1×+0.7
2017Dec 29, 20172.5×−1.9
2016Dec 30, 20164.4×–

More Can-Fite BioPharma figures

See a number that looks wrong?